Infectious disease | Australian Biotech Company News

Home Tags Infectious disease

Biotechnology

Changing Attitudes on Vaccine and Public Health Investment

BioChannel - July 8, 2020

Biotechnology

How Immuno-Oncology Contributes to the Fight Against Covid-19

BioChannel - July 6, 2020

Biotechnology

CureVac Bids to Develop First mRNA Coronavirus Vaccine

BioChannel - February 3, 2020

Biotechnology

Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic

BioChannel - January 3, 2020

Biotechnology

Danish Smallpox Vaccine Gets FDA Approval to Fight Bioterrorism

BioChannel - September 25, 2019

Biotechnology

Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss...

BioChannel - September 16, 2019

Biotechnology

Nabriva Therapeutics Gets FDA Green Light for Pneumonia Antibiotic

BioChannel - August 20, 2019

Biotechnology

First Potential Chlamydia Vaccine Shows Early Promise

BioChannel - August 16, 2019

Biotechnology

European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?

BioChannel - April 25, 2019

Stay connected

Recent posts

Life in the Time of Coronavirus

BioChannel - July 10, 2020

Study pinpoints brain cells that trigger sugar cravings and consumption

BioChannel - July 10, 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

BioChannel - July 10, 2020

Random article

Life in the Time of Coronavirus

Study pinpoints brain cells that trigger sugar cravings and consumption

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

VarmX bags €32m in Series B round – European Biotechnology News